证券记录 · 已归档季度
RXST
RxSight, Inc. · Healthcare · Medical - Devices
17被追踪持有人
0Δ持有人
14.88M持有股份
$133.76M报告持仓市值
+1新建仓位
−1清仓
动量输入(同类管理人): 持有人广度 0.0% · 股份流向 +5.5% · 净新建仓位 0.0% · 公式
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 31.92K | $154,807 | n/a | n/a |
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | n/a | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | n/a | n/a |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | n/a | −1 |
| Q2 2024 | 12 | n/a | 2.73M | $164.29M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 2.70M | -10.1% | $24.30M | 0.0% | ▼ Trim | 2 | SEC ↗ ×8 |
| 2 | Millennium Management ✦ | 2.19M | +130.6% | $19.72M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 2.15M | -5.8% | $19.30M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 4 | D. E. Shaw & Co. ✦ | 1.83M | +38.8% | $16.49M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 1.29M | +25.5% | $11.60M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 844.65K | n/a | $7.59M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 7 | State Street Global Advisors ✦ (被动) | 824.14K | -10.1% | $7.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 739.30K | -14.3% | $6.65M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Baillie Gifford ✦ | 686.32K | +46.4% | $6.17M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 10 | Two Sigma Investments ✦ | 662.42K | +50.4% | $5.96M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 373.55K | n/a | $3.36M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | JPMorgan Chase ✦ | 205.76K | n/a | $1.85M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 13 | Point72 Asset Management ✦ | 155.29K | 新增 | $1.40M | 0.0% | New | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 138.70K | -67.5% | $1.25M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 33.53K | +45.1% | $302,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 26.04K | -59.5% | $234,074 | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 17 | Fidelity (FMR) ✦ | 21.48K | -86.3% | $193,122 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $1.40M | 0.0% |
已清仓
| Wellington Management | $9.46M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 162 持有人, 37.72M 股份, $223.80M 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Goldshleger Ilya
Officer · 2.04K 股 · $14,205
Sep 02
Kurtz Ronald M MD
Officer · 5.10K 股 · $35,496
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 19
SC 13G: Point72 Asset Management, L.P.
Aug 04
SC 13G/A: MILLENNIUM MANAGEMENT LLC
Jul 17
SC 13G: BlackRock Portfolio Management LLC
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据